Full Press Release Details
THERAPEUTICS LIMITED
of this announcement
+securities to be quoted are:
issued, transferred or re-classified as a result of options being exercised or other +convertible securities being converted
number of +securities to be quoted
| ASX +security code | Security description | Number of +securities to be quoted | Issue date | |||
| ATH | ORDINARY FULLY PAID | 161 | 14/03/2025 |
to next page for full details of the announcement
1 - Entity and announcement details
THERAPEUTICS LIMITED
(the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX
| 1.2 Registered number type | Registration number | ||
| ABN | 37080699065 |
Date of this announcement
The +securities to be quoted are:
issued, transferred or re-classified as a result of options being exercised or other +convertible securities being converted
The +class of +securities to be quoted is:
+securities in a class that is already quoted on ASX ("existing class")
and type of +securities to be quoted (existing class) where issue has not previously been notified to ASX in an
+securities converting into additional +securities in an existing class
+security code and description
: OPTION EXPIRING 31-AUG-2026
+security code and description
: ORDINARY FULLY PAID
| Please state the number of options that were exercised or other +convertible securities that were converted | The first date the options were exercised or other +convertible securities were converted | The last date the options were exercised or other +convertible securities were converted | |||
| 161 | 13/3/2025 |
all of the options or other +convertible securities on issue of that type (ie have all of those options now been exercised or have all
of those convertible securities now been converted)?
right of the holder of the options or other +convertible securities to receive the +underlying securities is being satisfied by:
issue of new +securities
underlying +securities being received by the holder are:
to be, but are not yet, quoted by ASX
the options being exercised or other +convertible securities being converted issued under an +employee incentive scheme?
the +securities to be quoted rank equally in all respects from their issue date with the existing issued +securities in that class?
of +securities to be quoted
the +securities being issued for a cash consideration?
| In what currency is the cash consideration being paid? | What is the issue price per +security? | ||
| AUD - Australian Dollar | AUD 0.01000000 |
other information the entity wishes to provide about the +securities to be quoted
Issued capital following quotation
the quotation of the +securities the subject of this application, the issued capital of the entity will comprise:
figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix
2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.
Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the +securities subject of this
| ASX +security code and description | Total number of +securities on issue | ||
| ATH : ORDINARY FULLY PAID | 6,656,848,880 | ||
| ATHO : OPTION EXPIRING 31-AUG-2026 | 932,611,269 |
Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX)
| ASX +security code and description | Total number of +securities on issue | ||
| ATHAAE : OPTION EXPIRING 29-NOV-2026 EX $0.0375 | 14,250,000 | ||
| ATHAAG : OPTION EXPIRING 29-NOV-2026 EX $0.0238 | 11,900,000 | ||
| ATHAAB : OPTION EXPIRING 17-SEP-2025 EX $0.09 | 35,000,000 | ||
| ATHAAK : OPTION EXPIRING 30-DEC-2027 EX $0.01 | 170,000,000 | ||
| ATHAAH : OPTION EXPIRING 19-DEC-2026 EX $0.0105 | 8,000,000 | ||
| ATHAB : OPTION EXPIRING 13-MAR-2029 EX US$0.0031 | 62,500,000 | ||
| ATHAA : OPTION EXPIRING 13-MAR-2029 EX $0.004 | 20,166,667 | ||
| ATHAC : OPTION EXPIRING 21-MAR-2029 EX US$0.003 | 120,000,000 | ||
| ATHAAD : OPTION EXPIRING 06-JAN-2026 EX $0.032 | 91,392,720 |